Trial Details
COMPLETEDBasic Information
| Clinical ID | c3124 |
|---|---|
| Identifier | NCT02499783 |
| Trial Title | Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: adalimumab|OTHER: placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-08-17 |
|---|---|
| Primary Completion Date | 2017-05-19 |
| Completion Date | 2017-12-15 |